Neuroendocrine tumours trials in China

In China 62 Also abroad 244

62 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Beijing, Chengdu, Guangzhou, Shanghai
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
No phaseTaking people
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
Where
Xi'an
Age
18 years to 75 years
People
35
Run by
Xijing Hospital
See details and how to joinNCT06914427
Phase 3Taking people
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Linyi, Luoyang, Nanning, Shanghai, Wuhan, Xiamen, Xi'an, Zhengzhou
Age
18 years and over
People
390 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00
No phaseEnrolling by invitation
Liver Transplantation Versus Conventional Medical Therapy for Low-Grade GEP-NET With Liver Metastases
Where
Tianjin
Age
18 years to 70 years
People
100
Run by
Chiyi Chen
See details and how to joinNCT07913113
Phase 1Taking people
A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
115
Run by
Biokin (Shanghai) Biopharmaceutical Co., Ltd.
See details and how to joinNCT06505824
No phaseNot yet taking people in China
Immunotherapy in Neuroendocrine Carcinoma of the Cervix
Where
Beijing
Age
18 years to 100 years
People
150
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07911423
Phase 2/3Taking people
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Where
Hong Kong
Age
18 years and over
People
440 worldwide
Run by
Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00
Phase 1/2Not yet taking people in China
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
Where
Nanning, Shanghai
Age
18 years and over
People
60 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00
No phaseTaking people
Incremental Value of Delayed 68Ga-DOTATATE PET/MR in the Detection of Liver Metastases
Where
Fuzhou
Age
30 years to 74 years
People
46
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07898904
No phaseEnrolling by invitation
Oxaliplatin-Based Adjuvant Therapy for Gastrointestinal Neuroendocrine Carcinoma**
Where
Beijing
Age
18 years to 75 years
People
42
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07891572
Phase 1/2Taking people
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
265
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06283719
Phase 3Not yet taking people in China
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Where
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jinan, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shengyang, Taiyuan, Tianjin, Wenzhou, Xiamen, Xi’an, Xinxiang, Xuzhou, Zhengzhou
Age
18 years and over
People
280
Run by
Nanjing Leads Biolabs Co.,Ltd
See details and how to joinNCT07720193
No phaseNot yet taking people in China
Multi-omics Study of Cervical Neuroendocrine Carcinoma
Where
Beijing
Age
18 years to 100 years
People
120
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07879339
No phaseTaking people
A Comparative Study of Patients Undergoing Surgery for Pituitary Neuroendocrine Tumors Detected by Different Ways
Where
Beijing
Age
1 year to 85 years
People
5,000
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07835412
Phase 2Taking people
Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer
Where
Beijing
Age
18 years to 80 years
People
200
Run by
Tingting Yuan
See details and how to joinNCT07733024
No phaseTaking people
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
Where
Xiamen
Age
18 years to 80 years
People
80
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07458906
Phase 2Taking people
Lenvatinib Plus Chemotherapy for pNET Liver Metastases
Where
Beijing
Age
18 years to 75 years
People
80
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07835893
Phase 3Not yet taking people in China
ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine Carcinoma
Where
Zhengzhou
Age
18 years to 75 years
People
440
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07833839
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Where
Beijing, Shanghai
Age
12 years to 100 years
People
240 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00
No phaseNot yet taking people in China
Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors
Where
Xiamen
Age
18 years and over
People
60
Run by
Yefeng
See details and how to joinNCT07780539
No phaseTaking people
Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors
Where
Guangzhou
Age
18 years to 75 years
People
174
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07759960
Phase 1/2Taking people
An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
Where
Beijing
Age
18 years to 75 years
People
40
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06038461
Phase 2Taking people
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Where
Chengdu, Hangzhou, Jinan, Nanchang, Shanghai
Age
18 years and over
People
204 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00
Phase 2/3Taking people
A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms
Where
Shanghai
Age
12 years and over
People
85
Run by
Sinotau Pharmaceutical Group
See details and how to joinNCT06398444
Phase 2Not yet taking people in China
AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
Where
Baotou, Taiyuan, Tianjin, Tongliao
Age
18 years to 75 years
People
56
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07712094